TW202333649A - Oil-in-water emulsion cosmetic - Google Patents
Oil-in-water emulsion cosmetic Download PDFInfo
- Publication number
- TW202333649A TW202333649A TW111150416A TW111150416A TW202333649A TW 202333649 A TW202333649 A TW 202333649A TW 111150416 A TW111150416 A TW 111150416A TW 111150416 A TW111150416 A TW 111150416A TW 202333649 A TW202333649 A TW 202333649A
- Authority
- TW
- Taiwan
- Prior art keywords
- acid
- component
- oil
- water
- mass
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 53
- 239000007764 o/w emulsion Substances 0.000 title abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 64
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 34
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 21
- 239000000194 fatty acid Substances 0.000 claims abstract description 21
- 229930195729 fatty acid Natural products 0.000 claims abstract description 21
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims abstract description 18
- 229960000401 tranexamic acid Drugs 0.000 claims abstract description 18
- 235000005152 nicotinamide Nutrition 0.000 claims abstract description 17
- 239000011570 nicotinamide Substances 0.000 claims abstract description 17
- 229960003966 nicotinamide Drugs 0.000 claims abstract description 16
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 14
- 229910044991 metal oxide Inorganic materials 0.000 claims abstract description 13
- 150000004706 metal oxides Chemical class 0.000 claims abstract description 12
- 150000002148 esters Chemical class 0.000 claims abstract description 9
- 229920003169 water-soluble polymer Polymers 0.000 claims abstract description 8
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 54
- 239000004615 ingredient Substances 0.000 claims description 41
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 28
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims description 27
- 235000021355 Stearic acid Nutrition 0.000 claims description 22
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims description 22
- 239000008117 stearic acid Substances 0.000 claims description 22
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 20
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 14
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 12
- 239000005639 Lauric acid Substances 0.000 claims description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 235000021314 Palmitic acid Nutrition 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 7
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 7
- 239000004094 surface-active agent Substances 0.000 claims description 6
- 239000011787 zinc oxide Substances 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 claims description 5
- 239000004408 titanium dioxide Substances 0.000 claims description 5
- 230000008859 change Effects 0.000 abstract description 25
- 239000008346 aqueous phase Substances 0.000 abstract description 5
- 230000007704 transition Effects 0.000 abstract 1
- -1 polyethylene Polymers 0.000 description 35
- 238000011156 evaluation Methods 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 238000011282 treatment Methods 0.000 description 21
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 18
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 18
- 239000012071 phase Substances 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- 229920002125 Sokalan® Polymers 0.000 description 16
- 239000000787 lecithin Substances 0.000 description 16
- 235000010445 lecithin Nutrition 0.000 description 16
- 229940067606 lecithin Drugs 0.000 description 16
- 239000003921 oil Substances 0.000 description 16
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 16
- 229920001577 copolymer Polymers 0.000 description 14
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 13
- 239000011734 sodium Substances 0.000 description 13
- SHZIWNPUGXLXDT-UHFFFAOYSA-N ethyl hexanoate Chemical compound CCCCCC(=O)OCC SHZIWNPUGXLXDT-UHFFFAOYSA-N 0.000 description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 238000000034 method Methods 0.000 description 10
- 239000006071 cream Substances 0.000 description 9
- 239000002245 particle Substances 0.000 description 9
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 8
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 8
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 8
- 239000005642 Oleic acid Substances 0.000 description 8
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 8
- 239000004205 dimethyl polysiloxane Substances 0.000 description 8
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 8
- 239000012188 paraffin wax Substances 0.000 description 8
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 7
- 239000004359 castor oil Substances 0.000 description 7
- 235000019438 castor oil Nutrition 0.000 description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- OWRMXHRUFYLLQP-UHFFFAOYSA-N [3-[2,3-bis(16-methylheptadecanoyloxy)propoxy]-2-hydroxypropyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C OWRMXHRUFYLLQP-UHFFFAOYSA-N 0.000 description 6
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 6
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 6
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 5
- 229910019142 PO4 Inorganic materials 0.000 description 5
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 238000010306 acid treatment Methods 0.000 description 5
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 5
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 5
- 229960002216 methylparaben Drugs 0.000 description 5
- 239000010452 phosphate Substances 0.000 description 5
- 235000011007 phosphoric acid Nutrition 0.000 description 5
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 5
- 239000000230 xanthan gum Substances 0.000 description 5
- 229920001285 xanthan gum Polymers 0.000 description 5
- 235000010493 xanthan gum Nutrition 0.000 description 5
- 229940082509 xanthan gum Drugs 0.000 description 5
- PQUXFUBNSYCQAL-UHFFFAOYSA-N 1-(2,3-difluorophenyl)ethanone Chemical compound CC(=O)C1=CC=CC(F)=C1F PQUXFUBNSYCQAL-UHFFFAOYSA-N 0.000 description 4
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- 229920006037 cross link polymer Polymers 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 210000000245 forearm Anatomy 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 229940047670 sodium acrylate Drugs 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 229940104261 taurate Drugs 0.000 description 4
- 239000010936 titanium Substances 0.000 description 4
- 229910052719 titanium Inorganic materials 0.000 description 4
- 238000012549 training Methods 0.000 description 4
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 3
- FJVWEMXTRKQOPG-NRFANRHFSA-N (2s)-2-(octadecylamino)pentanedioic acid Chemical compound CCCCCCCCCCCCCCCCCCN[C@H](C(O)=O)CCC(O)=O FJVWEMXTRKQOPG-NRFANRHFSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 3
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 3
- IEKHISJGRIEHRE-UHFFFAOYSA-N 16-methylheptadecanoic acid;propan-2-ol;titanium Chemical compound [Ti].CC(C)O.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O IEKHISJGRIEHRE-UHFFFAOYSA-N 0.000 description 3
- PSQFOYNNWBCJMY-UHFFFAOYSA-N 2-[2-(2-hydroxyethoxy)ethoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCCOCCO PSQFOYNNWBCJMY-UHFFFAOYSA-N 0.000 description 3
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- 235000021357 Behenic acid Nutrition 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 229940116226 behenic acid Drugs 0.000 description 3
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229940074052 glyceryl isostearate Drugs 0.000 description 3
- 229940075529 glyceryl stearate Drugs 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 3
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 150000004671 saturated fatty acids Chemical class 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- ZLNXPOHTTBSBIH-HNNXBMFYSA-N (2s)-2-(dodecylamino)pentanedioic acid Chemical compound CCCCCCCCCCCCN[C@H](C(O)=O)CCC(O)=O ZLNXPOHTTBSBIH-HNNXBMFYSA-N 0.000 description 2
- JVTIXNMXDLQEJE-UHFFFAOYSA-N 2-decanoyloxypropyl decanoate 2-octanoyloxypropyl octanoate Chemical compound C(CCCCCCC)(=O)OCC(C)OC(CCCCCCC)=O.C(=O)(CCCCCCCCC)OCC(C)OC(=O)CCCCCCCCC JVTIXNMXDLQEJE-UHFFFAOYSA-N 0.000 description 2
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 125000005250 alkyl acrylate group Chemical group 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 229960001631 carbomer Drugs 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229940062000 polyglyceryl-2 triisostearate Drugs 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229940068968 polysorbate 80 Drugs 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- OFEACQDMSUYJHD-KRWDZBQOSA-N (2s)-6-amino-2-(dodecylamino)hexanoic acid Chemical compound CCCCCCCCCCCCN[C@H](C(O)=O)CCCCN OFEACQDMSUYJHD-KRWDZBQOSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- QEYATHUQKXAPIM-NRFANRHFSA-N (4s)-4-amino-5-octadecoxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCCCCCCCCOC(=O)[C@@H](N)CCC(O)=O QEYATHUQKXAPIM-NRFANRHFSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- AOWCOHYBGYRYGE-UHFFFAOYSA-N 1-[2,3-bis(2-oxopropoxy)propoxy]propan-2-one Chemical compound CC(=O)COCC(OCC(C)=O)COCC(C)=O AOWCOHYBGYRYGE-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IFBDFMPSOCGRKA-UHFFFAOYSA-N 1-octadecoxyoctadecane;phosphoric acid Chemical compound OP(O)(O)=O.CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC IFBDFMPSOCGRKA-UHFFFAOYSA-N 0.000 description 1
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- DNACJYZYGAJDBK-UHFFFAOYSA-N 16-methylheptadecanoic acid propane-1,2,3-triol Chemical compound OCC(O)CO.CC(C)CCCCCCCCCCCCCCC(O)=O.CC(C)CCCCCCCCCCCCCCC(O)=O DNACJYZYGAJDBK-UHFFFAOYSA-N 0.000 description 1
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 1
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 1
- MQFYRUGXOJAUQK-UHFFFAOYSA-N 2-[2-[2-(2-octadecanoyloxyethoxy)ethoxy]ethoxy]ethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOCCOCCOCCOC(=O)CCCCCCCCCCCCCCCCC MQFYRUGXOJAUQK-UHFFFAOYSA-N 0.000 description 1
- FRGIOIALHUOUTR-UHFFFAOYSA-N 2-[4-(diethylamino)-2-hydroxybenzoyl]hexyl benzoate Chemical compound C=1C=C(N(CC)CC)C=C(O)C=1C(=O)C(CCCC)COC(=O)C1=CC=CC=C1 FRGIOIALHUOUTR-UHFFFAOYSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 2-dodecanoyloxyethyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCC ZVUNTIMPQCQCAQ-UHFFFAOYSA-N 0.000 description 1
- UADWUILHKRXHMM-UHFFFAOYSA-N 2-ethylhexyl benzoate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1 UADWUILHKRXHMM-UHFFFAOYSA-N 0.000 description 1
- 229940106004 2-ethylhexyl benzoate Drugs 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- ZUYVPAKYYMBQBT-UHFFFAOYSA-N 3,4-diethyl-2-hexoxyphenol Chemical compound CCCCCCOC1=C(O)C=CC(CC)=C1CC ZUYVPAKYYMBQBT-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- XHMJFIZTASOMJO-UHFFFAOYSA-N C[Si]1(O[Si](O[Si](O[Si](O[Si](O1)(C)C)(C)C)(C)C)(C)C)C.C[Si]1(O[Si](O[Si](O[Si](O[Si](O1)(C)C)(C)C)(C)C)(C)C)C Chemical compound C[Si]1(O[Si](O[Si](O[Si](O[Si](O1)(C)C)(C)C)(C)C)(C)C)C.C[Si]1(O[Si](O[Si](O[Si](O[Si](O1)(C)C)(C)C)(C)C)(C)C)C XHMJFIZTASOMJO-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- QKMUNXQTOPXAII-OMYYHYAVSA-N N[C@@H](CCCCN)C(=O)O.N[C@@H](CCC(=O)OCCCCCCCCCCCC)C(=O)OCCCCCCCCCCCC Chemical compound N[C@@H](CCCCN)C(=O)O.N[C@@H](CCC(=O)OCCCCCCCCCCCC)C(=O)OCCCCCCCCCCCC QKMUNXQTOPXAII-OMYYHYAVSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000376571 Paraceras Species 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 239000006087 Silane Coupling Agent Substances 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- DPOPAJRDYZGTIR-UHFFFAOYSA-N Tetrazine Chemical compound C1=CN=NN=N1 DPOPAJRDYZGTIR-UHFFFAOYSA-N 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- BAECOWNUKCLBPZ-HIUWNOOHSA-N Triolein Natural products O([C@H](OCC(=O)CCCCCCC/C=C\CCCCCCCC)COC(=O)CCCCCCC/C=C\CCCCCCCC)C(=O)CCCCCCC/C=C\CCCCCCCC BAECOWNUKCLBPZ-HIUWNOOHSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 description 1
- 229930003537 Vitamin B3 Natural products 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 229940048053 acrylate Drugs 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- UADWUILHKRXHMM-ZDUSSCGKSA-N benzoflex 181 Natural products CCCC[C@H](CC)COC(=O)C1=CC=CC=C1 UADWUILHKRXHMM-ZDUSSCGKSA-N 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229940075510 carbopol 981 Drugs 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960003993 chlorphenesin Drugs 0.000 description 1
- 229910000423 chromium oxide Inorganic materials 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229910001651 emery Inorganic materials 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- 235000019233 fast yellow AB Nutrition 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 1
- IIRDTKBZINWQAW-UHFFFAOYSA-N hexaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCO IIRDTKBZINWQAW-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- YZUUTMGDONTGTN-UHFFFAOYSA-N nonaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCO YZUUTMGDONTGTN-UHFFFAOYSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 229940096994 peg-10 glyceryl stearate Drugs 0.000 description 1
- 229940032076 peg-15 glyceryl stearate Drugs 0.000 description 1
- 229940117924 peg-150 stearate Drugs 0.000 description 1
- 229940078498 peg-5 glyceryl stearate Drugs 0.000 description 1
- 229940023750 peg-60 glyceryl isostearate Drugs 0.000 description 1
- 125000005010 perfluoroalkyl group Chemical group 0.000 description 1
- 229910052628 phlogopite Inorganic materials 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229940104256 sodium taurate Drugs 0.000 description 1
- FWFUWXVFYKCSQA-UHFFFAOYSA-M sodium;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C FWFUWXVFYKCSQA-UHFFFAOYSA-M 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229950003429 sorbitan palmitate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019160 vitamin B3 Nutrition 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Description
本發明係關於水中油(oil-in-water)型乳化化妝品。The present invention relates to oil-in-water emulsified cosmetics.
粉底、妝前底霜等彩妝化妝品,係藉由其肌膚補正效果而具有用以使肌膚看起來均勻之即時性功能的化妝品。近年來,藉由將摻合在準藥品(quasi‐drug)中的有效成分摻合在此等粉底、妝前底霜等彩妝化妝品中,而在即時性的肌膚補正效果以外,還歌頌因持續使用有效成分所得之肌膚改善效果的產品,其需求高漲。例如,菸鹼醯胺為維生素之一種,具有皺紋改善效果、皮膚障壁能力的改善、美白效果、肌質改善效果等對於皮膚的效果。已知傳明酸(tranexamic acid)由於具有抗炎症作用,而在利用來作為醫藥品之有效成分的同時,具有抑制黑色素產生的作用。包含作用不同的此等二種成分的組成物,被期待對於多種肌膚煩惱帶來多方面的效果。然而,此等有效成分由於是電解質,且摻合在粉底、妝前底霜等彩妝化妝品中,而會損害粉體分散性,所以有在外觀顏色與塗抹顏色容易產生落差的課題。尤其,在水相中包含此等電解質與金屬氧化物兩者的水中油型化妝品中,此等課題特別顯著地出現。迄今為止,亦已針對使粉末分散性提升的方法進行各種研討。Make-up cosmetics such as foundation and makeup primer have an immediate function of making the skin look even through its skin-correcting effect. In recent years, active ingredients blended in quasi-drugs have been blended into makeup products such as foundations and makeup primers. In addition to immediate skin correction effects, they are also praised for their long-lasting effects. The demand for products that use active ingredients to improve skin is rising. For example, nicotinamide is one of the vitamins that has effects on the skin such as wrinkle improvement, skin barrier improvement, whitening, and skin improvement. It is known that tranexamic acid has an anti-inflammatory effect and is used as an active ingredient in pharmaceuticals. It is also known to have an effect of inhibiting melanin production. A composition containing these two ingredients with different effects is expected to bring various effects to various skin troubles. However, since these active ingredients are electrolytes and are mixed into makeup cosmetics such as foundation and makeup primer, they will impair the powder dispersion, so there is a problem that the appearance color and the application color are easy to produce a gap. In particular, these problems appear particularly prominently in oil-in-water cosmetics containing both these electrolytes and metal oxides in the water phase. Until now, various studies have been conducted on methods for improving powder dispersibility.
已知有:藉由將粉體以矽烷偶合劑處理並與特定親水性樹脂複合化來使用的方法,而使分散性提升的技術(例如,專利文獻1);和將粉體表面以聚乙烯吡咯啶酮處理而使用的方法(例如,專利文獻2)。 [先前技術文獻] [專利文獻] There are known techniques for improving dispersibility by treating powder with a silane coupling agent and compounding it with a specific hydrophilic resin (for example, Patent Document 1); and coating the surface of the powder with polyethylene. A method using pyrrolidone treatment (for example, Patent Document 2). [Prior technical literature] [Patent Document]
專利文獻1:日本特開平10-45949號公報 專利文獻2:日本特開2001-48731號公報 Patent Document 1: Japanese Patent Application Publication No. 10-45949 Patent Document 2: Japanese Patent Application Publication No. 2001-48731
[發明欲解決之課題][Problem to be solved by the invention]
然而,雖能夠藉由使用上述技術而使粉體的分散性提升,但於水中油型乳化組成物,係有在塗抹之際,將其延展開時使用感會緩緩地變化的情形等。伴隨此情形,有化妝膜成為不均勻的情形、停止之平順度不佳的情形等,亦有於高溫時發生排液等穩定性不佳的情形。However, although the dispersibility of the powder can be improved by using the above-mentioned technology, the oil-in-water emulsion composition may have a situation where the feeling of use gradually changes when it is spread out during application. Along with this, the makeup film may become uneven, the smoothness of the stop may be poor, and the stability may be poor such as drainage at high temperatures.
因此,本發明係提供一種於外觀顏色與塗抹顏色無落差、無高溫下之排液、化妝膜之均勻性、停止之平順度、塗抹時無使用感之變化上優異的水中油型乳化化妝品。 [用以解決課題之手段] Therefore, the present invention provides an oil-in-water emulsified cosmetic that is excellent in that there is no difference between the appearance color and the applied color, no drainage at high temperatures, uniformity of the makeup film, smoothness of stopping, and no change in the feeling of use during application. [Means used to solve problems]
鑑於上述實際情形,本發明人等為了解決上述問題而反覆進行努力研究的結果,發現藉由組合傳明酸、菸鹼醯胺、金屬氧化物、飽和脂肪酸或其酯及水溶性高分子,而可獲得於外觀顏色與塗抹顏色無落差、無高溫下之排液、化妝膜之均勻性、停止之平順度、塗抹時無使用感之變化上優異的水中油型化妝品,遂而完成本發明。In view of the above-mentioned actual situation, the inventors of the present invention have made repeated efforts to study in order to solve the above-mentioned problems, and found that by combining tranexamic acid, nicotinamide, metal oxides, saturated fatty acids or their esters, and water-soluble polymers, The present invention was completed by obtaining an oil-in-water cosmetic that is excellent in that there is no difference between the appearance color and the application color, no drainage at high temperatures, uniformity of the makeup film, smoothness of the stop, and no change in the feeling of use during application.
即本發明為: [1]提供一種水中油型乳化化妝品,其特徵為含有以下的成分(A)~(E): (A)傳明酸0.5~10%質量%、 (B)菸鹼醯胺1~10質量%、 (C)金屬氧化物1~30質量%、 (D)碳數12~20之脂肪酸或其酯、 (E)水溶性高分子, 且前述成分(A)與前述成分(B)的合計含有質量為3~14質量%,而至少在外部水相中含有前述成分(C)。 [2]提供如[1]記載之水中油型乳化化妝品,其中前述成分(C)之金屬氧化物為選自由二氧化鈦、氧化鋅、及氧化鐵所組成的群組之一種或二種以上。 [3]提供如[1]或[2]記載之水中油型乳化化妝品,其中前述成分(D)之脂肪酸為選自由月桂酸、肉豆蔻酸、棕櫚酸、及硬脂酸所組成的群組之一種或二種以上。 [4]提供如[1]或[2]記載之水中油型乳化化妝品,其進一步含有成分(F)磷酸系界面活性劑。 [5]提供如[1]或[2]記載之水中油型乳化化妝品,其在外部水相中及內部油相中含有前述成分(C),且內部油相中之前述成分(C)的含有質量對化妝品中之前述成分(C)的含量之比率為0.35~0.8。 [發明之效果] That is, the present invention is: [1] Provide an oil-in-water emulsion cosmetic, characterized by containing the following ingredients (A) to (E): (A) Tranexamic acid 0.5 to 10% by mass, (B) Nicotinamide 1 to 10% by mass, (C) Metal oxide 1 to 30% by mass, (D) Fatty acids with 12 to 20 carbon atoms or their esters, (E) Water-soluble polymer, The total mass content of the component (A) and the component (B) is 3 to 14% by mass, and at least the external water phase contains the component (C). [2] Provide the oil-in-water type emulsified cosmetics as described in [1], wherein the metal oxide of the component (C) is one or more selected from the group consisting of titanium dioxide, zinc oxide, and iron oxide. [3] Provide the oil-in-water type emulsified cosmetics as described in [1] or [2], wherein the fatty acid of the component (D) is selected from the group consisting of lauric acid, myristic acid, palmitic acid, and stearic acid. One or more than two kinds. [4] Provides the oil-in-water type emulsified cosmetics according to [1] or [2], which further contains component (F) a phosphoric acid-based surfactant. [5] Provide an oil-in-water emulsion cosmetic as described in [1] or [2], which contains the aforementioned component (C) in an external water phase and an internal oil phase, and the internal oil phase contains the aforementioned component (C) The ratio of the content mass to the content of the aforementioned ingredient (C) in the cosmetic is 0.35 to 0.8. [Effects of the invention]
依據本發明,則可提供一種水中油型乳化化妝品,其兼具外觀顏色與塗抹顏色無落差、無高溫下之排液、化妝膜之均勻性、停止之平順度、塗抹時無使用感之變化,所以能夠應用利用於妝前底霜、粉底等。According to the present invention, it is possible to provide an oil-in-water emulsified cosmetic that has no difference in appearance color and application color, no drainage at high temperatures, uniformity of the makeup film, smoothness of stop, and no change in the feel of use during application. , so it can be used in makeup primer, foundation, etc.
[用以實施發明的形態][Form used to implement the invention]
以下,針對本發明之較佳實施形態進行詳細說明。惟,本發明並不限定於以下之較佳實施形態,在本發明之範圍內可自由地變更。又,於本說明書,「%」只要沒有特別說明,則意指「質量%」。又,使用「~」表示數值範圍的情形,其範圍包含兩端之數值。Hereinafter, preferred embodiments of the present invention will be described in detail. However, the present invention is not limited to the following preferred embodiments, and can be freely modified within the scope of the present invention. In addition, in this specification, "%" means "mass %" unless otherwise specified. Also, when "~" is used to indicate a numerical range, the range includes the values at both ends.
本發明中之成分(A)傳明酸,係以反式-4-(胺基甲基)環己烷-1-甲酸所表示的胺基酸之一種。傳明酸有時對於皮膚以美白效果、抗炎症效果來使用,有時亦作為止血劑使用。The component (A) tranexamic acid in the present invention is one of the amino acids represented by trans-4-(aminomethyl)cyclohexane-1-carboxylic acid. Tranexamic acid is sometimes used for skin whitening and anti-inflammatory effects, and is sometimes used as a hemostatic agent.
本發明中之成分(A)的含量為0.5~10質量%(以下,僅省略為「%」)。較佳為1%以上,更佳為2%以上。又,較佳為8%以下,更佳為5%以下。又,較佳為1~8%,更佳為2~5%。若於此範圍,則在無高溫下之排液、停止之平順度、塗抹時無使用感之變化等觀點為更優異,所以更佳。若成分(A)的含量小於0.5%,則有無法獲得塗抹時無使用感之變化的情形,若超過10%,則有於無高溫下之排液、停止之平順度等上不佳的情形。The content of component (A) in the present invention is 0.5 to 10% by mass (hereinafter, only "%" is abbreviated). Preferably it is 1% or more, More preferably, it is 2% or more. Moreover, it is preferably 8% or less, more preferably 5% or less. Moreover, 1 to 8% is preferable, and 2 to 5% is more preferable. If it is within this range, it is more excellent in terms of no drainage at high temperatures, smoothness of stopping, and no change in the feeling of use during application, so it is more preferable. If the content of component (A) is less than 0.5%, there may be cases where there is no change in the feeling of use when applied. If it exceeds 10%, there may be problems with drainage at high temperatures, smoothness of stopping, etc. .
本發明所使用的成分(B)菸鹼醯胺,係菸鹼酸(維生素B3/菸酸(niacin))之醯胺化合物。菸鹼醯胺為水溶性維生素,係為維生素B群之一的周知物質,可從天然物(米糠等)萃取或者是藉由周知方法而合成。具體而言,可使用第17版日本藥典中所收錄者。The component (B) nicotinic acid amide used in the present invention is an amide compound of nicotinic acid (vitamin B3/niacin). Nicotinamide is a water-soluble vitamin and a well-known substance that is one of the B vitamins. It can be extracted from natural products (rice bran, etc.) or synthesized by well-known methods. Specifically, those included in the 17th edition of the Japanese Pharmacopoeia can be used.
本發明中之成分(B)的含量為1~10%。較佳為3%以上,更佳為4%以上。又,較佳為10%以下,更佳為9%以下。又,較佳為3~10%,更佳為4~9%。若為此範圍,則在無高溫之排液、塗抹時無使用感之變化等觀點為更優異,所以更佳。若成分(B)的含量小於1%,則有無法獲得塗抹時無使用感之變化的情形,若超過10%,則有於無高溫下之排液、停止之平順度等上不佳的情形。The content of component (B) in the present invention is 1 to 10%. More preferably, it is 3% or more, and more preferably, it is 4% or more. Moreover, it is preferably 10% or less, more preferably 9% or less. Furthermore, 3 to 10% is preferred, and 4 to 9% is more preferred. If it is within this range, it is more excellent in terms of no high-temperature discharge and no change in the feeling of use during application, so it is more preferable. If the content of component (B) is less than 1%, it may not be possible to obtain a change in the feeling of use when applied. If it exceeds 10%, there may be problems with drainage at high temperatures, smoothness of stopping, etc. .
又,成分(A)與成分(B)的合計含有質量為3~14質量%。較佳為4~10%,更佳為5~8%。若為此範圍,則在停止之平順度等的觀點為優異,所以更佳。Moreover, the total mass content of component (A) and component (B) is 3-14 mass %. Preferably, it is 4-10%, More preferably, it is 5-8%. If it is within this range, it is excellent from the viewpoint of smoothness of stopping and so on, so it is more preferable.
本發明中之成分(C)金屬氧化物,若為可使用於通常之化妝品者,則不特別藉由球狀、板狀、針狀等之形狀、煙霧狀、微粒子、顏料級等之粒徑、多孔質、無孔質等之粒子結構等而限制,任一者皆可使用。就金屬氧化物而言,並未特別限定,但可列舉例如氧化鋅、氧化鐵、二氧化鈦、氧化鋯、氧化鈰、氧化鉻等,可使用彼等之一種或二種以上。此等之中,從所謂化妝膜之均勻性的觀點來看,又更佳為選自由氧化鋅、二氧化鈦、及氧化鐵所組成的群組之一種或二種以上。粒徑並未特別限定,可配合使用目的來選擇。於本發明中,從所謂化妝膜之均勻性的觀點來看,若平均粒徑為0.01~1μm之範圍則更佳。平均粒徑係指藉由利用影像分析裝置(LUZEX AP,NIRECO公司製)之測定而求得的中位直徑D50值。又,非對稱形狀的情形,於本發明中,係將從最大粒徑之分布求得的中位直徑D50設為平均粒徑。As long as the metal oxide of component (C) in the present invention can be used in ordinary cosmetics, it is not particularly limited by the shape of spheres, plates, needles, etc., the particle size of smoke, fine particles, pigment grade, etc. It is limited by the particle structure such as porous or non-porous, but any one can be used. The metal oxide is not particularly limited, but examples thereof include zinc oxide, iron oxide, titanium dioxide, zirconium oxide, cerium oxide, chromium oxide, and the like, and one or more of these may be used. Among these, from the viewpoint of the uniformity of the cosmetic film, one or two or more types selected from the group consisting of zinc oxide, titanium dioxide, and iron oxide are more preferred. The particle size is not particularly limited and can be selected according to the purpose of use. In the present invention, from the viewpoint of the uniformity of the cosmetic film, it is more preferable if the average particle diameter is in the range of 0.01 to 1 μm. The average particle diameter refers to the median diameter D50 value obtained by measurement using an image analysis device (LUZEX AP, manufactured by NIRECO). In the case of an asymmetric shape, in the present invention, the median diameter D50 obtained from the distribution of the maximum particle diameter is regarded as the average particle diameter.
成分(C)之金屬氧化物,亦可使用其表面為經疏水化處理之狀態者。可列舉例如甲基氫聚矽氧烷處理、二甲基聚矽氧烷處理等聚矽氧處理、三乙氧基辛醯基矽烷處理等烷基烷氧基矽烷處理、全氟烷基磷酸酯處理、全氟烷基烷氧基矽烷處理等氟處理、三異硬脂酸異丙氧鈦鹽(isopropyl titanium triisostearate)處理、硬脂酸處理、肉豆蔻酸處理等脂肪酸處理、月桂醯基離胺酸處理、二月桂醯基麩胺酸離胺酸Na處理、硬脂醯基麩胺酸2Na處理、月桂醯基天冬胺酸Na等N-醯基胺基酸處理、卵磷脂處理、氫化卵磷脂處理等磷脂質處理、聚氧化乙烯等聚氧化烯烴處理、神經醯胺處理、金屬皂處理等,可將此等之一種或二種以上組合而使用。疏水化處理所使用的處理劑之處理量並未特別限制,但從外觀顏色與塗抹顏色無落差的觀點來看,相對於金屬氧化物,較佳為0.1~20%,更佳為0.3~10%。The metal oxide of component (C) may also be used if its surface is in a hydrophobized state. Examples include methyl hydrogen polysiloxane treatment, polysiloxane treatment such as dimethyl polysiloxane treatment, alkyl alkoxysilane treatment such as triethoxyoctylsiloxane treatment, perfluoroalkyl phosphate treatment, Fluorine treatment such as perfluoroalkyl alkoxysilane treatment, isopropyl titanium triisostearate treatment, stearic acid treatment, myristic acid treatment and other fatty acid treatment, lauryl lysine acid treatment , dilauryl glutamate lysine Na treatment, stearyl glutamate 2Na treatment, lauryl aspartate Na and other N-acyl amino acid treatments, lecithin treatment, hydrogenated lecithin treatment Phospholipid treatment, polyoxyalkylene treatment such as polyethylene oxide, ceramide treatment, metal soap treatment, etc. can be used alone or in combination of two or more. The treatment amount of the treatment agent used in the hydrophobization treatment is not particularly limited, but from the viewpoint of no difference between the appearance color and the painting color, 0.1 to 20% of the metal oxide is preferred, and 0.3 to 10% is more preferred. %.
本發明中之成分(C)的含量為1~30%,較佳為1%以上,更佳為2%以上,進一步更佳為3%以上。又,較佳為25%以下,更佳為22%以下,進一步更佳為20%以下。又,較佳為1~25%,更佳為2~22%,進一步更佳為3~20%。若為此範圍,則於外觀顏色與塗抹顏色無落差、化妝膜之均勻性上更優異,所以更佳。The content of component (C) in the present invention is 1 to 30%, preferably 1% or more, more preferably 2% or more, further preferably 3% or more. Moreover, it is preferably 25% or less, more preferably 22% or less, and still more preferably 20% or less. Moreover, 1-25% is preferable, 2-22% is more preferable, and 3-20% is further more preferable. If it is within this range, it is better because there is no difference between the appearance color and the applied color, and the uniformity of the makeup mask is better.
本發明中之成分(C)被包含在外部水相中。在外觀顏色與塗抹顏色無落差、無使用感等之觀點,成分(C)較佳為包含在外部水相中及內部油相中,且內部油相中之前述成分(C)的含有質量對化妝品中之前述成分(C)的含量之比率較佳為0.35~0.8,更佳為0.5~0.7。若為此範圍,則於外觀顏色與塗抹顏色無落差、無使用感等上更優異,所以更佳。Ingredient (C) in the present invention is contained in the external aqueous phase. From the viewpoint of no difference between the appearance color and the applied color, and no feeling of use, etc., the component (C) is preferably contained in the external water phase and the internal oil phase, and the content mass of the component (C) in the internal oil phase is preferably The content ratio of the aforementioned component (C) in cosmetics is preferably 0.35 to 0.8, more preferably 0.5 to 0.7. If it is within this range, it is more excellent in that there is no difference between the appearance color and the application color, and there is no usability, so it is better.
本發明中之成分(D)碳數12~20之脂肪酸或其酯,係碳數12~20之脂肪酸、或者是脂肪酸與具有至少1個以上羥基的化合物之酯。就具有至少1個以上羥基的化合物而言,可列舉一元醇、多元醇、甘油或彼等之衍生物等。(D)之脂肪酸係碳數為12~20,可為直鏈或者是分支的飽和或不飽和之脂肪酸,可列舉例如,月桂酸、肉豆蔻酸、棕櫚酸、硬脂酸、異硬脂酸、12-羥基硬脂酸、棕櫚油酸、油酸、亞麻油酸、次亞麻油酸、花生油酸、二十碳五烯酸、異十六酸等,但並不限定於此等。其中較佳者為碳數12~20之飽和脂肪酸,更佳為月桂酸、肉豆蔻酸、棕櫚酸、硬脂酸,進一步更佳為棕櫚酸及硬脂酸。就脂肪酸酯而言,可列舉二月桂酸PEG-8、月桂酸PEG-12、月桂酸PEG-30氫化蓖麻油、月桂酸PEG-40氫化蓖麻油、月桂酸PEG-50氫化蓖麻油、月桂酸PEG-60氫化蓖麻油、二月桂酸PEG-12、二月桂酸PEG-16、硬脂酸山梨糖醇酐、硬脂酸PEG-5、PEG-5甘油硬脂酸酯、硬脂酸PEG-10、PEG-10甘油硬脂酸酯、PEG-15甘油硬脂酸酯、硬脂酸PEG-30、硬脂酸PEG-40、硬脂酸PEG-55、硬脂酸PEG-150、硬脂酸PEG-100、PEG-30甘油硬脂酸酯、PEG-40甘油硬脂酸酯、二硬脂酸PEG-150、異硬脂酸PEG-6、PEG-8甘油異硬脂酸酯、異硬脂酸PEG-10、PEG-15甘油異硬脂酸酯、異硬脂酸PEG-12、PEG-25甘油異硬脂酸酯、PEG-60甘油異硬脂酸酯、PEG-60甘油二異硬脂酸酯、三異硬脂酸PEG-50三羥甲基丙烷、油酸山梨糖醇酐、油酸PEG-6、油酸PEG-10、油酸PEG-40山梨糖醇酐、PCA異硬脂酸甘油醇醚-25(PCA Glycereth-25 Isostearate)、山梨醇聚醚六硬脂酸酯-150(Sorbeth-150 Hexastearate)、三油酸甘油酯PEG-40 (PEG-40 Glyceryl Trioleate)、三油酸甘油酯PEG-60等。其中較佳者為碳數12~20之硬脂酸與PEG之酯,更佳為硬脂酸PEG-40、硬脂酸PEG-55。Component (D) in the present invention is a fatty acid having 12 to 20 carbon atoms or an ester thereof, which is a fatty acid having 12 to 20 carbon atoms, or an ester of a fatty acid and a compound having at least one hydroxyl group. Examples of compounds having at least one hydroxyl group include monohydric alcohols, polyhydric alcohols, glycerin, and derivatives thereof. The fatty acid system (D) has a carbon number of 12 to 20 and can be a linear or branched saturated or unsaturated fatty acid. Examples include lauric acid, myristic acid, palmitic acid, stearic acid, and isostearic acid. , 12-hydroxystearic acid, palmitoleic acid, oleic acid, linoleic acid, hypolinoleic acid, arachidonic acid, eicosapentaenoic acid, isohexadecanoic acid, etc., but are not limited to these. Among them, saturated fatty acids having 12 to 20 carbon atoms are preferred, lauric acid, myristic acid, palmitic acid, and stearic acid are more preferred, and palmitic acid and stearic acid are still more preferred. Examples of fatty acid esters include dilauric acid PEG-8, lauric acid PEG-12, lauric acid PEG-30 hydrogenated castor oil, lauric acid PEG-40 hydrogenated castor oil, lauric acid PEG-50 hydrogenated castor oil, and lauric acid PEG-50 hydrogenated castor oil. Acid PEG-60 hydrogenated castor oil, PEG-12 dilaurate, PEG-16 dilaurate, sorbitan stearate, PEG-5 stearate, PEG-5 glyceryl stearate, PEG stearate -10, PEG-10 glyceryl stearate, PEG-15 glyceryl stearate, PEG-30 stearate, PEG-40 stearate, PEG-55 stearate, PEG-150 stearate, hard PEG-100 fatty acid, PEG-30 glyceryl stearate, PEG-40 glyceryl stearate, PEG-150 distearate, PEG-6 isostearate, PEG-8 glyceryl isostearate, PEG-10 isostearate, PEG-15 glyceryl isostearate, PEG-12 isostearate, PEG-25 glyceryl isostearate, PEG-60 glyceryl isostearate, PEG-60 glycerin Diisostearate, triisostearate PEG-50 trimethylolpropane, oleic acid sorbitan, oleic acid PEG-6, oleic acid PEG-10, oleic acid PEG-40 sorbitan, PCA Glycereth-25 Isostearate, Sorbeth-150 Hexastearate, PEG-40 Glyceryl Trioleate ), triolein PEG-60, etc. Among them, the ester of stearic acid and PEG having 12 to 20 carbon atoms is preferred, and stearic acid PEG-40 and stearic acid PEG-55 are more preferred.
就此種成分(D)之市售品而言,可列舉純化硬脂酸700V(花王股份有限公司製)、硬脂酸65(Miyoshi Oil & Fat Co., Ltd.製)、異硬脂酸EX(KOKYU ALCOHOL KOGYO CO., LTD.製)、EDENOR系列(EMERY OLEOCHEMICALS MALAYSIA公司製)、NIKKOL MYS-40V、NIKKOL MYS-55V系列(Nikko Chemicals Co., Ltd.製)、EMALEX系列(Nihon Emulsion Co., Ltd.製)等。Examples of commercially available products of the component (D) include purified stearic acid 700V (manufactured by Kao Co., Ltd.), stearic acid 65 (manufactured by Miyoshi Oil & Fat Co., Ltd.), and isostearic acid EX (KOKYU ALCOHOL KOGYO CO., LTD.), EDENOR series (EMERY OLEOCHEMICALS MALAYSIA), NIKKOL MYS-40V, NIKKOL MYS-55V series (Nikko Chemicals Co., Ltd.), EMALEX series (Nihon Emulsion Co.) , Ltd.) etc.
本發明中之成分(D)的含量未特別限制,但相對於水中油型乳化化妝料全體,較佳為0.1%以上,更佳為0.5%以上。又,較佳為5%以下,更佳為3%以下。又,較佳為0.1~5%,更佳為0.5~3%。若為此範圍,則於外觀顏色與塗抹顏色無落差上更優異,所以更佳。The content of component (D) in the present invention is not particularly limited, but it is preferably 0.1% or more, more preferably 0.5% or more, based on the entire oil-in-water emulsified cosmetic. Moreover, it is preferably 5% or less, more preferably 3% or less. Moreover, 0.1-5% is preferable, and 0.5-3% is more preferable. If it is within this range, it is better because there is no difference between the appearance color and the painted color, so it is better.
本發明中之成分(E)水溶性高分子,若為可使用於通常之化妝品者,則任一者皆可使用。就水溶性高分子而言,並未特別限定,但較佳為摻合選自丙烯醯胺系共聚物、羧基乙烯基聚合物的一種類、或二種類以上。就丙烯醯胺系共聚物而言,可列舉包含至少一種源自丙烯醯基二甲基牛磺酸鹽之構成單元(所謂單體單元)的聚合物。就上述丙烯醯基二甲基牛磺酸鹽而言,可列舉丙烯醯基二甲基牛磺酸鈉等。例如,丙烯酸與丙烯醯基二甲基牛磺酸鹽的共聚物、丙烯酸羥基乙酯與丙烯醯基二甲基牛磺酸鹽的共聚物、丙烯酸與丙烯酸鹽與丙烯醯胺與丙烯醯基二甲基牛磺酸鹽的共聚物等。就市售品而言,可列舉例如SIMULGEL EG(SEPPICSA公司製,(丙烯酸Na/丙烯醯基二甲基牛磺酸Na)共聚物)、SIMULGEL NS(SEPPIC SA公司製,(丙烯酸羥基乙酯/丙烯醯基二甲基牛磺酸Na)共聚物)等。羧基乙烯基聚合物係可於其單體構成、分子量等無特別限制地使用,可無特別限制地使用市售的各種羧基乙烯基聚合物。就此等市售品而言,可列舉例如,由Lubrizol(股)所販售的Carbopol 940、Carbopol 941、Carbopol 934、Carbopol 980、Carbopol 981、Carbopol 2984、Carbopol 5940、Carbopol ETD2050、Carbopol Ultrez10;由和光純藥工業(股)所販售的Cintalen K、Cintalen L、Cintalen M等。As long as the water-soluble polymer of component (E) in the present invention can be used in ordinary cosmetics, any one can be used. The water-soluble polymer is not particularly limited, but it is preferable to blend one, or two or more types selected from the group consisting of acrylamide copolymers and carboxyvinyl polymers. Examples of the acrylamide-based copolymer include polymers containing at least one structural unit (so-called monomer unit) derived from acrylamide dimethyltaurate. Examples of the above-mentioned acryldimethyltaurate include sodium acryldimethyltaurate and the like. For example, copolymers of acrylic acid and acrylic dimethyl taurate, copolymers of hydroxyethyl acrylate and acrylic dimethyl taurate, acrylic acid and acrylic acid salts and acrylamide and acrylic dimethyl taurate. Copolymers of methyl taurate, etc. Examples of commercially available products include SIMULGEL EG (manufactured by SEPPICSA Co., Ltd., (Na acrylate/acryloyldimethyltaurate Na) copolymer), SIMULGEL NS (manufactured by SEPPIC SA Co., Ltd., (hydroxyethyl acrylate/ Acrylyldimethyltaurate Na) copolymer), etc. The carboxyvinyl polymer can be used without particular restrictions on its monomer composition, molecular weight, etc., and various commercially available carboxyvinyl polymers can be used without particular limitations. Examples of such commercially available products include Carbopol 940, Carbopol 941, Carbopol 934, Carbopol 980, Carbopol 981, Carbopol 2984, Carbopol 5940, Carbopol ETD2050, and Carbopol Ultrez10 sold by Lubrizol Co., Ltd.; Cintalen K, Cintalen L, Cintalen M, etc. sold by Koko Pure Chemical Industries, Ltd.
本發明中之成分(E)的含量並未特別限定,但相對於水中油型乳化化妝品總量,較佳為0.05%以上,更佳為0.15%以上。又,較佳為0.45%以下,更佳為0.35%以下。又,較佳為0.05~0.45%,更佳為0.15~0.35%。若為此範圍,則於外觀顏色與塗抹顏色無落差、化妝膜之均勻性等上更優異,所以更佳。The content of component (E) in the present invention is not particularly limited, but relative to the total amount of oil-in-water emulsified cosmetics, it is preferably 0.05% or more, and more preferably 0.15% or more. Moreover, it is preferably 0.45% or less, more preferably 0.35% or less. Moreover, 0.05-0.45% is preferable, and 0.15-0.35% is more preferable. If it is within this range, it is better because there is no difference between the appearance color and the applied color, and the uniformity of the makeup film is superior.
本發明可進一步摻合成分(F)磷酸系界面活性劑。磷酸系界面活性劑,係指將高級醇或其聚氧化烯(polyoxyalkylene)衍生物的末端進行磷酸酯化而成之物,其包含藉由適當鹼將殘存的氫氧基中和而成之鹽。其中,又較佳為聚氧乙烯加成烷基醚磷酸類及其鹽類,但並不限定於此,可使用一種或組合二種以上而使用。就含量而言,若為0.01~1%,則在塗抹時無使用感之變化等觀點為較佳。就市售品而言,有HOSTAPHAT KW340D、HOSTAPHAT KL340D(Clariant (Japan) K.K.製)等。In the present invention, component (F) phosphoric acid-based surfactant can be further blended. Phosphoric acid-based surfactants refer to products obtained by phosphate-esterifying the terminals of higher alcohols or polyoxyalkylene derivatives thereof, and include salts in which residual hydroxyl groups are neutralized with an appropriate base. . Among them, polyoxyethylene-added alkyl ether phosphoric acids and their salts are preferred, but they are not limited thereto, and one type or two or more types may be used in combination. In terms of content, 0.01 to 1% is preferable from the viewpoint of no change in the feeling of use during application. Commercially available products include HOSTAPHAT KW340D, HOSTAPHAT KL340D (manufactured by Clariant (Japan) K.K.), and the like.
本發明之水中油型乳化化妝品中,除上述成分(A)~(F)以外,可於無損本發明之效果的範圍內,適當地含有通常之皮膚外用劑所使用的成分。可含有例如高級醇、烴油、酯油、蠟類、矽酮油等油劑、界面活性劑、水溶性高分子、多元醇、低級醇等水性成分、成分(C)以外之粉體、紫外線吸收劑、抗氧化劑、抗菌劑、防腐劑、保濕劑、pH調整劑、清涼劑、維生素類、美容成分、香料等。The oil-in-water type emulsified cosmetics of the present invention may appropriately contain, in addition to the above-mentioned components (A) to (F), components commonly used in external skin preparations within a range that does not impair the effects of the present invention. May contain, for example, higher alcohols, hydrocarbon oils, ester oils, waxes, silicone oils and other oils, surfactants, water-soluble polymers, polyols, lower alcohols and other water-based ingredients, powders other than ingredient (C), and ultraviolet rays Absorbents, antioxidants, antibacterial agents, preservatives, moisturizers, pH adjusters, cooling agents, vitamins, beauty ingredients, fragrances, etc.
本發明之水中油型乳化化妝品,並未特別限定,可按照通常方法而製造。可列舉例如藉由以下而調製的方法:將含有成分(A)、(B)、(C)及(E)的水性成分均勻地溶解混合,將含(D)的油性成分均勻地溶解混合,於此添加混合水溶性成分,進行乳化,進一步因應需要而添加上述任意成分,將此等混合。The oil-in-water emulsified cosmetic of the present invention is not particularly limited and can be produced according to ordinary methods. For example, a method of preparing by uniformly dissolving and mixing the aqueous component containing the components (A), (B), (C), and (E), and uniformly dissolving and mixing the oily component containing (D), can be cited, Here, water-soluble ingredients are added and mixed to emulsify, and if necessary, any of the above-mentioned ingredients are added and mixed.
本發明之水中油型乳化化妝品,並不特別限定,但作為成液狀、固形狀、凝膠狀、乳液狀、乳霜狀等任一性質皆可。The oil-in-water type emulsified cosmetic of the present invention is not particularly limited, and may be in any form such as liquid, solid, gel, emulsion, or cream.
本發明之水中油型乳化化妝品,並不特別限定,但可利用作為例如皮膚用之化妝品,可例示例如化妝水、乳液、乳霜、美容液、按摩料、敷料、護手霜、身體乳液、身體乳霜、防曬霜、妝前底霜、粉底、BB乳霜等之彩妝化妝品,較佳為妝前底霜、粉底、BB乳霜等之彩妝化妝品。The oil-in-water type emulsified cosmetics of the present invention is not particularly limited, but can be used as cosmetics for skin, for example, lotions, emulsions, creams, beauty lotions, massage agents, dressings, hand creams, body lotions, Body cream, sunscreen, makeup primer, foundation, BB cream, etc., preferably makeup primer, foundation, BB cream, etc.
又,本發明亦可能採用以下之構成。 <1>一種水中油型乳化化妝品,其特徵為含有以下的成分(A)~(E): (A)傳明酸0.5~10%質量%、 (B)菸鹼醯胺1~10質量%、 (C)金屬氧化物1~30質量%、 (D)碳數12~20之脂肪酸或其酯、 (E)水溶性高分子, 且前述成分(A)與前述成分(B)的合計含有質量為3~14質量%,而至少在外部水相中含有前述成分(C)。 <2>如<1>記載之水中油型乳化化妝品,其中前述成分(C)之金屬氧化物為選自由二氧化鈦、氧化鋅、及氧化鐵所組成的群組之一種或二種以上。 <3>如<1>或<2>記載之水中油型乳化化妝品,其中前述成分(D)之脂肪酸為選自由月桂酸、肉豆蔻酸、棕櫚酸、及硬脂酸所組成的群組之一種或二種以上。 <4>如<1>~<3>中任一項記載之水中油型乳化化妝品,其進一步含有成分(F)磷酸系界面活性劑。 <5>如<1>~<4>中任一項記載之水中油型乳化化妝品,其在外部水相中及內部油相中含有前述成分(C),且內部油相中之前述成分(C)的含有質量對化妝品中之前述成分(C)的含量之比率為0.35~0.8。 [實施例] In addition, the present invention may also adopt the following configuration. <1> An oil-in-water emulsified cosmetic, characterized by containing the following ingredients (A) to (E): (A) Tranexamic acid 0.5 to 10% by mass, (B) Nicotinamide 1 to 10% by mass, (C) Metal oxide 1 to 30% by mass, (D) Fatty acids with 12 to 20 carbon atoms or their esters, (E) Water-soluble polymer, The total mass content of the component (A) and the component (B) is 3 to 14% by mass, and at least the external water phase contains the component (C). <2> The oil-in-water type emulsified cosmetics according to <1>, wherein the metal oxide of the component (C) is one or more selected from the group consisting of titanium dioxide, zinc oxide, and iron oxide. <3> The oil-in-water emulsion cosmetic as described in <1> or <2>, wherein the fatty acid of the component (D) is selected from the group consisting of lauric acid, myristic acid, palmitic acid, and stearic acid. One or more than two types. <4> The oil-in-water type emulsified cosmetics according to any one of <1> to <3>, which further contains component (F) a phosphoric acid-based surfactant. <5> The oil-in-water emulsified cosmetics according to any one of <1> to <4>, which contains the aforementioned component (C) in the external water phase and the internal oil phase, and the aforementioned component (C) in the internal oil phase The ratio of the content mass of C) to the content of the aforementioned ingredient (C) in the cosmetic is 0.35 to 0.8. [Example]
於以下列舉實施例而詳細說明本發明。又,此等並不對本發明有任何限定。The following examples are given to illustrate the present invention in detail. In addition, these do not limit the present invention in any way.
實施例1~20及比較例1~6:水中油型乳化化妝品(粉底) 以下述所示製造方法調製實施例1~20及比較例1~6,針對A.外觀顏色與塗抹顏色無落差、B.無高溫下之排液、C.化妝膜之均勻性、D.停止之平順度、E.塗抹時無使用感之變化,藉由下述評價方法進行評價。 Examples 1 to 20 and Comparative Examples 1 to 6: Oil-in-water emulsified cosmetics (foundation) Examples 1 to 20 and Comparative Examples 1 to 6 were prepared according to the manufacturing method shown below. A. No difference between appearance color and application color, B. No drainage at high temperature, C. Uniformity of cosmetic film, D. Stop. E. There is no change in the feeling of use when applying, and the smoothness is evaluated by the following evaluation method.
[表1] (%)
[表2] (%)
[表3] (%)
(製造方法) A.將成分(1)~(11)均勻地混合。 B.將成分(12)~(26)加熱至80℃,均勻地混合。 C.將A添加至B中,於80℃進行乳化。 D.將C填充於容器中,獲得水中油型乳化化妝品。 (manufacturing method) A. Mix ingredients (1) to (11) evenly. B. Heat ingredients (12) to (26) to 80°C and mix them uniformly. C. Add A to B and emulsify at 80°C. D. Fill C in the container to obtain oil-in-water emulsified cosmetics.
(評價方法) A.外觀顏色與塗抹顏色無落差 選擇10名接受過官能評價訓練之20歲至40歲的女性,組成能以一定基準評價的專門小組。該專門小組以下述絕對評價基準,將使用前之各試料的外觀的顏色與用手指將10mg之各試料在前臂往返10次延展開後的顏色的落差,進行5階段評價並給予評分。對於每個樣品,由所有小組成員的評分合計而算出其平均值,根據以下4階段判斷基準進行判斷。 (評價基準) (評分):(評價) 5:無落差 4:幾乎無落差 3:有些許落差 2:有落差 1:有很大落差 (判斷基準) (判斷):(評分的平均點) ◎:高於4.5 ○:高於3.5且4.5以下 △:高於2.5且3.5以下 ×:2.5以下 (evaluation method) A. There is no difference between the appearance color and the painted color Select 10 women aged 20 to 40 who have received sensory evaluation training to form a specialized group that can evaluate based on certain standards. Based on the following absolute evaluation standards, this panel evaluated the difference in color between the appearance of each sample before use and the color difference after spreading 10 mg of each sample 10 times back and forth on the forearm with fingers, and gave scores in five stages. For each sample, the scores of all panel members are summed up to calculate the average value, and the judgment is made based on the following four-stage judgment criteria. (evaluation criteria) (Rating): (evaluation) 5: No gap 4: Almost no gap 3: There is a slight gap 2: There is a gap 1: There is a big gap (Judgment criteria) (Judgment): (average point of ratings) ◎: higher than 4.5 ○: More than 3.5 and less than 4.5 △: More than 2.5 and less than 3.5 ×: 2.5 or less
B.無高溫下之排液 專門評價者以目視評價將各試料填充至玻璃瓶且在50℃的恆溫槽中保存1個月時的排液狀態,以下述絕對評價基準,進行5階段評價並給予評分,根據以下4階段判斷基準進行判斷。 (評價基準) (評分):(評價) 5:並未觀察到排液。 4:幾乎未觀察到排液。 3:些微觀察到排液。 2:觀察到排液。 1:觀察到相當多的排液。 (判斷基準) (判斷):(評分的平均點) ◎:高於4.5 ○:高於3.5且4.5以下 △:高於2.5且3.5以下 ×:2.5以下 B. No drainage under high temperature A dedicated evaluator visually evaluates the drained state when each sample is filled into a glass bottle and stored in a constant temperature bath at 50°C for 1 month. Based on the following absolute evaluation standards, a 5-stage evaluation is performed and a score is given. The judgment is based on the following 4 stages. judge based on benchmarks. (evaluation criteria) (Rating): (evaluation) 5: Drainage was not observed. 4: Almost no drainage was observed. 3: Drainage was slightly observed. 2: Drainage is observed. 1: Considerable drainage was observed. (Judgment criteria) (Judgment): (average point of ratings) ◎: higher than 4.5 ○: More than 3.5 and less than 4.5 △: More than 2.5 and less than 3.5 ×: 2.5 or less
C.化妝膜之均勻性 選擇10名接受過官能評價訓練之20歲至40歲的女性,組成能以一定基準評價的專門小組。該專門小組以下述絕對評價基準,將用手指將10mg之各試料在前臂往返10次延展開時的化妝膜之均勻性,進行5階段評價並給予評分。對於每個樣品,由所有小組成員的評分合計而算出其平均值,根據以下4階段判斷基準進行判斷。 (評價基準) (評分):(評價) 5:非常良好 4:良好 3:普通 2:略差 1:差 (判斷基準) (判斷):(評分的平均點) ◎:高於4.5 ○:高於3.5且4.5以下 △:高於2.5且3.5以下 ×:2.5以下 C. Uniformity of makeup film Select 10 women aged 20 to 40 who have received sensory evaluation training to form a specialized group that can evaluate based on certain standards. Based on the following absolute evaluation standards, this panel evaluated and graded the uniformity of the cosmetic film when 10 mg of each sample was spread on the forearm 10 times with fingers in 5 stages. For each sample, the scores of all panel members are summed up to calculate the average value, and the judgment is made based on the following four-stage judgment criteria. (evaluation criteria) (Rating): (evaluation) 5: Very good 4: Good 3: Normal 2: Slightly worse 1: Poor (Judgment criteria) (Judgment): (average point of ratings) ◎: higher than 4.5 ○: More than 3.5 and less than 4.5 △: More than 2.5 and less than 3.5 ×: 2.5 or less
D.停止之平順度 選擇10名接受過官能評價訓練之20歲至40歲的女性,組成能以一定基準評價的專門小組。該專門小組以下述絕對評價基準,將用手指將10mg之各試料在前臂往返10次延展開時的停止之平順度,進行5階段評價並給予評分。對於每個樣品,由所有小組成員的評分合計而算出其平均值,根據以下4階段判斷基準進行判斷。 (評價基準) (評分):(評價) 5:非常良好 4:良好 3:普通 2:略差 1:差 (判斷基準) (判斷):(評分的平均點) ◎:高於4.5 ○:高於3.5且4.5以下 △:高於2.5且3.5以下 ×:2.5以下 D.Smoothness of stopping Select 10 women aged 20 to 40 who have received sensory evaluation training to form a specialized group that can evaluate based on certain standards. Based on the following absolute evaluation standards, this panel evaluated and graded the smoothness of stopping when 10 mg of each sample was stretched back and forth 10 times on the forearm with fingers in 5 stages. For each sample, the scores of all panel members are summed up to calculate the average value, and the judgment is made based on the following four-stage judgment criteria. (evaluation criteria) (Rating): (evaluation) 5: Very good 4: Good 3: Normal 2: Slightly worse 1: Poor (Judgment criteria) (Judgment): (average point of ratings) ◎: higher than 4.5 ○: More than 3.5 and less than 4.5 △: More than 2.5 and less than 3.5 ×: 2.5 or less
E.塗抹時無使用感之變化 選擇10名接受過官能評價訓練之20歲至40歲的女性,組成能以一定基準評價的專門小組。該專門小組以下述絕對評價基準,將用手指將10mg之各試料在前臂往返10次延展開時無使用感之變化,進行5階段評價並給予評分。對於每個樣品,由所有小組成員的評分合計而算出其平均值,根據以下4階段判斷基準進行判斷。 (評價基準) (評分):(評價) 5:非常良好 4:良好 3:普通 2:略差 1:差 (判斷基準) (判斷):(評分的平均點) ◎:高於4.5 ○:高於3.5且4.5以下 △:高於2.5且3.5以下 ×:2.5以下 E. There is no change in the feeling of use when applying it Select 10 women aged 20 to 40 who have received sensory evaluation training to form a specialized group that can evaluate based on certain standards. Based on the following absolute evaluation standards, this panel evaluated and rated the results in five stages, including no change in the feeling of use when 10 mg of each sample was stretched back and forth on the forearm 10 times with fingers. For each sample, the scores of all panel members are summed up to calculate the average value, and the judgment is made based on the following four-stage judgment criteria. (evaluation criteria) (Rating): (evaluation) 5: Very good 4: Good 3: Normal 2: Slightly worse 1: Poor (Judgment criteria) (Judgment): (average point of ratings) ◎: higher than 4.5 ○: More than 3.5 and less than 4.5 △: More than 2.5 and less than 3.5 ×: 2.5 or less
從表1的結果可清楚得知,本發明品1~20之水中油型乳化化妝品,係與比較例1~6之水中油型乳化化妝品相比,而於「外觀顏色與塗抹顏色無落差」、「無高溫下之排液」、「化妝膜之均勻性」、「停止之平順度」、「塗抹時無使用感之變化」之全部為優異者。相對於此,含有過量成分(A)的比較例1,係於「外觀顏色與塗抹顏色無落差」、「無高溫下之排液」、「停止之平順度」、「塗抹時無使用感之變化」為不佳者。含有過量成分(B)的比較例2,係於「外觀顏色與塗抹顏色無落差」、「無高溫下之排液」、「化妝膜之均勻性」、「停止之平順度」、「塗抹時無使用感之變化」為不佳者。摻合過少量成分(A)與成分(B)的比較例3,係於「化妝膜之均勻性」、「塗抹時無使用感之變化」為不佳者。不含有成分(D)的比較例4,係於「外觀顏色與塗抹顏色無落差」、「無高溫下之排液」、「化妝膜之均勻性」為不佳者。含有碳數非為12~20的脂肪酸來替代成分(D)的比較例5,係於「無高溫下之排液」、「化妝膜之均勻性」為不佳者。於油系含有成分(C)之全部量的比較例6之水中油型乳化化妝品,係於「無高溫下之排液」、「化妝膜之均勻性」為不佳者。From the results in Table 1, it is clear that the oil-in-water type emulsified cosmetics of products 1 to 20 of the present invention have "no difference in appearance color and application color" when compared with the oil-in-water type emulsified cosmetics of Comparative Examples 1 to 6. , "No drainage at high temperatures", "Uniformity of the makeup film", "Smoothness of stopping", "No change in feel during application" are all excellent. On the other hand, Comparative Example 1, which contains an excessive amount of component (A), has "no difference between the appearance color and the application color", "no drainage at high temperatures", "smoothness of stopping", and "no feeling of use when applying." "Change" is not good. Comparative Example 2, which contains an excessive amount of ingredient (B), is based on "no difference between the appearance color and the applied color", "no drainage at high temperatures", "uniformity of the makeup film", "smoothness of stopping", "during application" "Changes without a sense of use" are considered poor quality. Comparative Example 3, which blended a small amount of Component (A) and Component (B), was unsatisfactory in terms of "uniformity of the makeup film" and "no change in feel during application". Comparative Example 4, which does not contain ingredient (D), was poor in terms of "no difference between the appearance color and the applied color", "no drainage at high temperatures", and "uniformity of the makeup film". Comparative Example 5, which contains a fatty acid with a carbon number other than 12 to 20 in place of component (D), was poor in terms of "no drainage at high temperatures" and "uniformity of the cosmetic film". The oil-in-water type emulsified cosmetics of Comparative Example 6, which contained the entire amount of component (C) in the oil system, was poor in "drainage without high temperature" and "uniformity of the cosmetic film".
實施例21 水中油型液狀粉底 (成分) (%) 1.傳明酸 3 2.菸鹼醯胺 4 3.丙烯酸鈉‧丙烯醯基二甲基 牛磺酸鈉共聚物混合物※1 0.66 4.純水 殘量 5.乙醇 2 6.1,3-丁二醇 15 7.紅色氧化鐵 0.2 8.黃色氧化鐵 0.8 9.經卵磷脂處理之氧化鈦 4 10.硬脂酸 1.3 11.聚氧乙烯硬脂醚磷酸※2 0.5 12.對甲氧基肉桂酸2-乙基己酯 6 13.甘油三(乙基己酸)酯 2.5 14.流動石蠟 1 15.二新戊四醇脂肪酸酯 1 16.三異硬脂酸二甘油酯 1 17.對羥基苯甲酸甲酯 0.15 ※1:SIMULGEL EG QD(SEPPIC公司) ※2:HOSTAPHAT KL340D(Clariant (Japan) K.K.) Example 21 Oil-in-water liquid foundation (Element) (%) 1. Tranexamic acid 3 2.Nicotinamide 4 3.Sodium acrylate‧Acrylyldimethyl Sodium taurate copolymer mixture※1 0.66 4. Remaining amount of pure water 5.Ethanol 2 6.1,3-Butanediol 15 7. Red iron oxide 0.2 8. Yellow iron oxide 0.8 9. Titanium oxide treated with lecithin 4 10. Stearic acid 1.3 11. Polyoxyethylene stearyl ether phosphate ※2 0.5 12. 2-Ethylhexyl p-methoxycinnamate 6 13. Glyceryl tris(ethylhexanoate) 2.5 14.Mobile paraffin 1 15. Dineopenterythritol fatty acid ester 1 16. Diglyceryl triisostearate 1 17. Methyl parahydroxybenzoate 0.15 ※1: SIMULGEL EG QD (SEPPIC company) ※2: HOSTAPHAT KL340D (Clariant (Japan) K.K.)
(製造方法) A.將成分(1)~(9)均勻地混合。 B.將成分(10)~(17)加熱至80℃,並均勻地混合。 C.將A添加至B中,在80℃進行乳化。 D.將C填充於容器中而獲得水中油型液狀粉底。 (manufacturing method) A. Mix ingredients (1) to (9) evenly. B. Heat ingredients (10) to (17) to 80°C and mix evenly. C. Add A to B and emulsify at 80°C. D. Fill C in the container to obtain oil-in-water liquid foundation.
如以上地進行而獲得的水中油型液狀粉底,係於外觀顏色與塗抹顏色無落差、無高溫下之排液、化妝膜之均勻性、停止之平順度、塗抹時無使用感之變化上優異者。The oil-in-water liquid foundation obtained by proceeding as above is characterized by no difference between the appearance color and the applied color, no drainage at high temperatures, uniformity of the makeup film, smoothness of the stop, and no change in the feeling of use during application. Outstanding ones.
實施例22 水中油型液狀粉底 (成分) (%) 1.傳明酸 4 2.菸鹼醯胺 6 3.黃原膠 0.25 4.純水 殘量 5.乙醇 2 6.1,3-丁二醇 15 7.紅色氧化鐵 0.1 8.黃色氧化鐵 0.4 9.經卵磷脂處理之氧化鈦 2 10.乙基己基甘油※3 0.2 11.氯菲那辛(chlorphenesin) 0.1 12.紅色氧化鐵 0.1 13.黃色氧化鐵 0.4 14.經卵磷脂處理之氧化鈦 2 15.聚胺基甲酸酯凝膠組成物※4 2 16.氮化硼 2 17.N-月桂醯基-L-離胺酸 3 18.單油酸山梨糖醇酐(HLB4.3)※5 0.5 19.對甲氧基肉桂酸2-乙基己酯 6 20.甘油三(乙基己酸)酯 1 21.二異硬脂醇蘋果酸酯 2.5 22.高熔點聚乙烯粉末 1 23.流動石蠟 1 24.二新戊四醇脂肪酸酯 1 25.三異硬脂酸二甘油酯 1 26.六角板狀氧化鋅(平均粒徑0.3μm) 1 ※3:ADEKA NOL GE-RF(ADEKA公司製) ※4:OILKEMIA 5S CC POLYMER(日本Lubrizol公司製) ※5:NIKKOL SO-10V(Nikko Chemicals Co.製) Example 22 Oil-in-water liquid foundation (Element) (%) 1. Tranexamic acid 4 2.Nicotinamide 6 3.Xanthan gum 0.25 4. Remaining amount of pure water 5.Ethanol 2 6.1,3-Butanediol 15 7. Red iron oxide 0.1 8. Yellow iron oxide 0.4 9. Titanium oxide treated with lecithin 2 10.Ethylhexylglycerin※3 0.2 11.Chlorphenesin 0.1 12. Red iron oxide 0.1 13. Yellow iron oxide 0.4 14. Titanium oxide treated with lecithin 2 15.Polyurethane gel composition※4 2 16. Boron nitride 2 17.N-lauryl-L-lysine acid 3 18.Sorbitan monooleate (HLB4.3)※5 0.5 19. 2-ethylhexyl p-methoxycinnamate 6 20. Glyceryl tri(ethylhexanoate) 1 21. Diisostearyl malate 2.5 22. High melting point polyethylene powder 1 23.Mobile paraffin 1 24. Dineopenterythritol fatty acid ester 1 25. Diglyceryl triisostearate 1 26. Hexagonal plate-shaped zinc oxide (average particle size 0.3μm) 1 ※3: ADEKA NOL GE-RF (made by ADEKA Corporation) ※4: OILKEMIA 5S CC POLYMER (manufactured by Japan Lubrizol Corporation) ※5: NIKKOL SO-10V (manufactured by Nikko Chemicals Co.)
(製造方法) A.將成分(1)~(11)均勻地混合。 B.將成分(12)~(26)加熱至80℃,並均勻地混合。 C.將A添加至B中,在80℃進行乳化。 D.將C填充於容器中而獲得水中油型液狀粉底。 (manufacturing method) A. Mix ingredients (1) to (11) evenly. B. Heat ingredients (12) to (26) to 80°C and mix evenly. C. Add A to B and emulsify at 80°C. D. Fill C in the container to obtain oil-in-water liquid foundation.
如以上地進行而獲得的水中油型液狀粉底,係於外觀顏色與塗抹顏色無落差、無高溫下之排液、化妝膜之均勻性、停止之平順度、塗抹時無使用感之變化上優異者。The oil-in-water liquid foundation obtained by proceeding as above is characterized by no difference between the appearance color and the applied color, no drainage at high temperatures, uniformity of the makeup film, smoothness of the stop, and no change in the feeling of use during application. Outstanding ones.
實施例23 水中油型液狀遮暇膏 (成分) (%) 1.傳明酸 2 2.菸鹼醯胺 7 3.羧基乙烯基聚合物 0.25 4.純水 殘量 5.乙醇 3 6.1,3-丁二醇 10 7.苯氧基乙醇 0.2 8.紅色氧化鐵 0.6 9.黃色氧化鐵 2.4 10.經神經醯胺處理之氧化鈦 12 11.棕櫚酸 1.8 12.鯊烷 0.1 13.碳酸丙烯酯 0.1 14.聚氧乙烯硬脂醚磷酸※2 0.5 15.甘油三(乙基己酸)酯 2.5 16.流動石蠟 1 17.三異硬脂酸二甘油酯 1 Example 23 Oil-in-water liquid concealer (Element) (%) 1. Tranexamic acid 2 2.Nicotinamide 7 3. Carboxyvinyl polymer 4. Remaining amount of pure water 5.Ethanol 3 6.1,3-Butanediol 10 7. Phenoxyethanol 0.2 8. Red iron oxide 0.6 9. Yellow iron oxide 2.4 10. Titanium oxide treated with ceramide 12 11. Palmitic acid 1.8 12. Squalane 0.1 13. Propylene carbonate 0.1 14.Polyoxyethylene stearyl ether phosphate ※2 0.5 15. Glyceryl tris(ethylhexanoate) 2.5 16.Mobile paraffin 1 17. Diglyceryl triisostearate 1
(製造方法) A.將成分(1)~(9)均勻地混合。 B.將成分(10)~(17)加熱至80℃,並均勻地混合。 C.將A添加至B中,在80℃進行乳化。 D.將C填充於容器中而獲得水中油型液狀遮暇膏。 (manufacturing method) A. Mix ingredients (1) to (9) evenly. B. Heat ingredients (10) to (17) to 80°C and mix evenly. C. Add A to B and emulsify at 80°C. D. Fill C in the container to obtain oil-in-water liquid concealer.
如以上地進行而獲得的水中油型液狀遮暇膏,係於外觀顏色與塗抹顏色無落差、無高溫下之排液、化妝膜之均勻性、停止之平順度、塗抹時無使用感之變化上優異者。The oil-in-water liquid concealer obtained by carrying out the above process has no gap between the appearance color and the applied color, no drainage at high temperatures, uniform makeup film, smooth stop, and no feeling of use when applying. Excellent in change.
實施例24:水中油型粉底 (成分) (%) 1.聚山梨醇酯80 0.5 2.硬脂酸甘油酯 0.5 3.倍半油酸山梨糖醇酐 0.5 4.棕櫚酸山梨糖醇酐 0.5 5.硬脂酸 1.5 6.卵磷脂 0.1 7.三(鯨蠟硬脂醇聚醚-4)磷酸酯 (triceteareth-4 Phosphate) 0.3 8.二十二醇 0.5 9.甲氧基肉桂酸乙基己酯 (ethylhexyl methoxycinnamate) 5 10.雙乙基己氧基苯酚甲氧基苯基三(bisethylhexyloxyphenol methoxyphenyltriazine) 1 11.甘油三(乙基己酸)酯 (triethylhexanoin) 1 12.聚甘油-2 三異硬脂酸酯 (polyglyceryl-2 triisostearate) 3 13.礦物油 0.5 14.二新戊四醇六(羥基硬脂酸/硬脂酸/松香酸)酯 0.5 15.月桂醯基麩胺酸二 (辛基十二基/植物固醇基/二十二基) 2 16.石蠟*6 1 17.聚二甲基矽氧烷(dimethicone)*7 3 18.氧化鈦(平均粒徑250nm)*8 5 19.氧化鐵*9 1 20.純水 殘量 21.BG 15 22.乙醇 5 23.TEA 1 24.苯氧基乙醇 0.2 25.磷酸2Na 0.1 26.磷酸Na 0.1 27.EDTA-2Na 0.1 28.(丙烯酸/丙烯酸烷酯(C10-C30))共聚物 0.01 29.卡波姆(carbomer) 0.2 30.結晶纖維素 0.005 31.結蘭膠(gellan gum) 0.005 32.丙烯酸酯類共聚物 (ACRYLATES COPOLYMER) 0.1 33.滑石 0.5 34.合成金雲母 1 35.無水矽酸 3 36.膨土 0.001 37.傳明酸 3 38.菸鹼醯胺 3 *6:PARACERA 256(PARAMELT公司製) *7:矽KF-96A(20CS)(信越化學工業公司製) *8:經卵磷脂2%處理的CR-50(石原產業) *9:以經三異硬酯醯基鈦酸異丙酯(Isopropyl triisostearoyl titanate)2%處理之紅色氧化鐵:經三異硬酯醯基鈦酸異丙酯2%處理之黃色氧化鐵:經三異硬酯醯基鈦酸異丙酯2%處理之黑色氧化鐵=0.15:0.8:0.05混合者 Example 24: Oil-in-water foundation (ingredients) (%) 1. Polysorbate 80 0.5 2. Glyceryl stearate 0.5 3. Sorbitan sesquioleate 0.5 4. Sorbitan palmitate 0.5 5. Stearic acid 1.5 6. Lecithin 0.1 7. Tris (ceteeareth-4 phosphate) 0.3 8. Behenyl alcohol 0.5 9. Methoxycinnamic acid ethyl Hexyl ester (ethylhexyl methoxycinnamate) 5 10. Bisethylhexyloxyphenol methoxyphenyltri (bisethylhexyloxyphenol methoxyphenyltriazine) 1 11. Triethylhexanoin 1 12. Polyglyceryl-2 triisostearate (polyglyceryl-2 triisostearate) 3 13. Mineral oil 0.5 14. Dineopentylene tetrazine Alcohol hexa(hydroxystearic acid/stearic acid/rosin acid) ester 0.5 15. Laurylglutamic acid bis(octyldodecyl/phytosterol/bisyl) 2 16. Paraffin*6 1 17. Dimethicone*7 3 18. Titanium oxide (average particle size 250nm)*8 5 19. Iron oxide*9 1 20. Pure water residual 21. BG 15 22. Ethanol 5 23 .TEA 1 24. Phenoxyethanol 0.2 25. 2Na phosphate 0.1 26. Na phosphate 0.1 27. EDTA-2Na 0.1 28. (Acrylic acid/alkyl acrylate (C10-C30)) copolymer 0.01 29. carbomer ) 0.2 30. Crystalline cellulose 0.005 31. Gellan gum 0.005 32. ACRYLATES COPOLYMER 0.1 33. Talc 0.5 34. Synthetic phlogopite 1 35. Anhydrous silicic acid 3 36. Bentonite 0.001 37. Tranexamic acid 3 38. Nicotinamide 3 *6: PARACERA 256 (manufactured by PARAMELT Co., Ltd.) *7: Silicon KF-96A (20CS) (manufactured by Shin-Etsu Chemical Industry Co., Ltd.) *8: Treated with 2% lecithin CR-50 (Ishihara Sangyo) *9: Red iron oxide treated with isopropyl triisostearoyl titanate 2%: Isopropyl triisostearoyl titanate 2% % treated yellow iron oxide: black iron oxide treated with 2% isopropyl triisostearyl titanate = 0.15:0.8:0.05 mixture
<製造方法> A.將成分(1)~(17)於75℃均勻地混合。 B.將成分(18)~(38)於75℃均勻地混合。 C.於75℃將A添加至B中乳化後,冷卻至30度為止,獲得水中油型粉底。 <Manufacturing method> A. Mix ingredients (1) to (17) uniformly at 75°C. B. Mix ingredients (18) to (38) uniformly at 75°C. C. Add A to B at 75°C to emulsify, then cool to 30°C to obtain an oil-in-water foundation.
如以上地進行而獲得的水中油型粉底,係於外觀顏色與塗抹顏色無落差、無高溫下之排液、化妝膜之均勻性、停止之平順度、塗抹時無使用感之變化上優異者。The oil-in-water foundation obtained by proceeding as above is excellent in that there is no difference between the appearance color and the applied color, no drainage at high temperatures, uniformity of the makeup film, smoothness of stopping, and no change in the feeling of use during application. .
實施例25 妝前底霜 (成分) (%) 1.1,3-丁二醇 10 2.甘油 5 3.三(鯨蠟硬脂醇聚醚-4)磷酸酯 0.1 4.聚山梨醇酯-80 1 5.經月桂醯基麩胺酸Na處理之 氧化鈦*10 4 6.經硬脂醯基麩胺酸2Na處理之 紅氧化鐵*11 0.1 7.經硬脂醯基麩胺酸2Na處理之 黃氧化鐵*12 0.1 8.經硬脂醯基麩胺酸2Na處理之 黑氧化鐵*13 0.1 9.三乙醇胺 0.9 10.純水 殘量 11.傳明酸 3 12.菸鹼醯胺 5 13.硬脂酸 1 14.鯨蠟硬脂醇 0.3 15.倍半油酸山梨糖醇酐 0.3 16.聚二甲基矽氧烷(動黏度10mm 2/s) 2 17.甲氧基肉桂酸乙基己酯 5 18.新戊二醇二癸酸酯 1 19.2,4-雙[{4-(2-乙基己基氧基) -2-羥基}-苯基]-6-(4-甲氧基苯基) -(1,3,5)-三 0.5 20.2-2‘-亞甲基雙{6-(苯并三唑-2-基) -4-(1,1,3,3-四甲基丁基)酚} 3 21.(聚二甲基矽氧烷/乙烯基聚二甲基 矽氧烷)交聯聚合物/聚二甲基 矽氧烷*14 2 22.羧基乙烯基聚合物 0.15 23.黃原膠 0.03 24.丙烯酸酯類共聚物 0.1 25.丙烯酸Na交聯聚合物 0.3 26.抗壞血酸2-葡萄糖苷 (ascorbic acid 2-glucoside) 0.3 27.香料 適量 28.(丙烯酸酯類/丙烯酸烷酯 (C10-30))交聯聚合物 0.2 29.纖維素*15 1 30.中空矽石*16 0.7 31.氧化鈦被覆雲母*17 1 32.苯氧基乙醇 0.1 33.內含甲氧基肉桂酸 乙基己酯的膠囊 4 *10:ASL-1 TiO2 MP-1133(大東化成工業公司製) *11:NAI-red R-516PS(100%)(三好化成公司製) *12:NAI yellow LL-100P(100%)(三好化成公司製) *13:NAI-black BL-100P(100%)(三好化成公司製) *14:KSG-16(信越化學工業公司製) *15:CELLULOBEADS S-10(大東化成工業公司製) *16:SILICA MICROBEAD BA-4(JGC C&C公司製) *17:COSMETICA SUPER RED N-5401S(CQV公司製) Example 25 Makeup primer (ingredients) (%) 1.1,3-butanediol 10 2. Glycerin 5 3. Tris(cetearyl ether-4) phosphate 0.1 4. Polysorbate 80 1 5. Titanium oxide treated with lauryl glutamic acid Na*10 4 6. Red iron oxide treated with 2Na stearylglutamic acid*11 0.1 7. Treated with 2Na stearylglutamic acid Yellow iron oxide*12 0.1 8. Black iron oxide treated with stearyl glutamic acid 2Na*13 0.1 9. Triethanolamine 0.9 10. Remaining pure water 11. Tranexamic acid 3 12. Nicotinamide 5 13 .Stearic acid 1 14. Cetearyl alcohol 0.3 15. Sesquioleic acid sorbitan 0.3 16. Polydimethylsiloxane (dynamic viscosity 10mm 2 /s) 2 17. Ethyl methoxycinnamate Hexyl ester 5 18. Neopentyl glycol didecanoate 1 19.2,4-bis[{4-(2-ethylhexyloxy)-2-hydroxy}-phenyl]-6-(4-methoxy phenyl)-(1,3,5)-tri 0.5 20.2-2'-Methylenebis{6-(benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol} 3 21.(Polydimethyl (vinyl polydimethylsiloxane) cross-linked polymer/polydimethylsiloxane*14 2 22. Carboxy vinyl polymer 0.15 23. Xanthan gum 0.03 24. Acrylic ester copolymer Material 0.1 25. Acrylic acid Na cross-linked polymer 0.3 26. Ascorbic acid 2-glucoside (ascorbic acid 2-glucoside) 0.3 27. Appropriate amount of fragrance 28. (Acrylates/alkyl acrylate (C10-30)) cross-linked polymer 0.2 29. Cellulose*15 1 30. Hollow silica*16 0.7 31. Titanium oxide-coated mica*17 1 32. Phenoxyethanol 0.1 33. Capsules containing ethylhexyl methoxycinnamate 4 *10 : ASL-1 TiO2 MP-1133 (manufactured by Daito Chemical Industry Co., Ltd.) *11: NAI-red R-516PS (100%) (manufactured by Miyoshi Chemical Co., Ltd.) *12: NAI yellow LL-100P (100%) (Miyoshi Chemical Co., Ltd. (manufactured by Shin-Etsu Chemical Industry Co., Ltd.) *13: NAI-black BL-100P (100%) (manufactured by Miyoshi Chemical Industry Co., Ltd.) *14: KSG-16 (manufactured by Shin-Etsu Chemical Industry Co., Ltd.) *15: CELLULOBEADS S-10 (manufactured by Daito Chemical Industry Co., Ltd.) *16 : SILICA MICROBEAD BA-4 (manufactured by JGC C&C) *17: COSMETICA SUPER RED N-5401S (manufactured by CQV)
(製造方法) A:將成分(1)~(8)均勻地以三滾輪機處理。 B:將A、成分(9)~(12)均勻地混合。 C:將成分(13)~(21)於75℃均勻分散。 D:將C加入B中,於75℃進行乳化。 E:將D冷卻至60℃。 F:將成分(22)~(33)加入E中,並均勻地混合。 G:將F冷卻至40℃。 H:將A添加至G中,並均勻地混合。 I:將H進行填充容器後,獲得妝前底霜。 (manufacturing method) A: Evenly process ingredients (1) to (8) with a three-roller machine. B: Mix A and components (9) to (12) evenly. C: Evenly disperse ingredients (13) to (21) at 75°C. D: Add C to B and emulsify at 75°C. E: Cool D to 60°C. F: Add ingredients (22) to (33) to E and mix evenly. G: Cool F to 40°C. H: Add A to G and mix evenly. I: After filling the container with H, a makeup primer is obtained.
如以上地進行而獲得的水中油型粉底,係於外觀顏色與塗抹顏色無落差、無高溫下之排液、化妝膜之均勻性、停止之平順度、塗抹時無使用感之變化上優異者。The oil-in-water foundation obtained by proceeding as above is excellent in that there is no difference between the appearance color and the applied color, no drainage at high temperatures, uniformity of the makeup film, smoothness of stopping, and no change in the feeling of use during application. .
實施例26 BB乳霜 (成分) (%) 1.PEG-10氫化蓖麻油 0.05 2.倍半油酸山梨糖醇酐 0.03 3.1,3-丁二醇 0.5 4.經聚氧化乙烯處理之氧化鈦 6 5.經氫化卵磷脂處理之滑石 0.2 6.紅氧化鐵(R-516-P:鈦工業公司製) 0.3 7.黃氧化鐵(LL-100P:鈦工業公司製) 0.3 8.黑氧化鐵(BL-100P:鈦工業公司製) 0.3 9.純水 殘量 10.二丙二醇 9 11.三乙醇胺 0.35 12.硬脂酸 1 13.二十二醇 1 14.聚二甲基矽氧烷(動黏度6mm 2/s) 1 15.流動石蠟 1 16.異壬酸異十三烷基酯 4 17.十甲基環五矽氧烷 (decamethylcyclopentasiloxane) 3 18.新戊二醇二-2-乙基己酸酯 (neopentyl glycol di-2-ethylhexanoate) 1 19.經聚矽氧處理之微粒子氧化鈦 3 20.PEG-9聚二甲基矽氧烷 0.4 21.對甲氧基肉桂酸2-乙基己酯 5 22.2-{4-(二乙基胺基)-2- 羥基苯甲醯基}苯甲酸己酯 1 23.(聚二甲基矽氧烷/苯基聚二甲基 矽氧烷/)交聯聚合物/二苯基甲矽烷 氧基苯基聚三甲基矽氧烷 3 24.羧基乙烯基聚合物 0.3 25.丙烯醯基二甲基牛磺酸銨/ 乙烯基吡咯啶酮)共聚物 0.7 26.卡波姆Na 0.5 27.傳明酸 3 28.菸鹼醯胺 1 29.香料 適量 Example 26 BB cream (ingredients) (%) 1. PEG-10 hydrogenated castor oil 0.05 2. Sorbitan sesquioleate 0.03 3. 1,3-butanediol 0.5 4. Titanium oxide treated with polyoxyethylene 6 5. Talc treated with hydrogenated lecithin 0.2 6. Red iron oxide (R-516-P: manufactured by Titanium Industrial Co., Ltd.) 0.3 7. Yellow iron oxide (LL-100P: manufactured by Titanium Industrial Co., Ltd.) 0.3 8. Black iron oxide (BL-100P: Made by Titanium Industrial Co., Ltd.) 0.3 9. Remaining pure water 10. Dipropylene glycol 9 11. Triethanolamine 0.35 12. Stearic acid 1 13. Behenyl alcohol 1 14. Polydimethylsiloxane ( Kinematic viscosity 6mm 2 /s) 1 15. Mobile paraffin 1 16. Isotridecyl isononanoate 4 17. Decamethylcyclopentasiloxane (decamethylcyclopentasiloxane) 3 18. Neopentyl glycol di-2-ethyl neopentyl glycol di-2-ethylhexanoate 1 19. Microparticle titanium oxide treated with polysiloxane 3 20. PEG-9 polydimethylsiloxane 0.4 21. p-Methoxycinnamic acid 2-ethyl Hexyl benzoate 5 22.2-{4-(diethylamino)-2-hydroxybenzoyl}hexyl benzoate 1 23.(Polydimethylsiloxane/phenylpolydimethylsiloxane /)Cross-linked polymer/diphenylsilyloxyphenyltrimethylsiloxane 3 24.Carboxyvinyl polymer 0.3 25.Ammonium acrylyldimethyltaurate/vinylpyrrolidone ) Copolymer 0.7 26. Carbomer Na 0.5 27. Tranexamic acid 3 28. Nicotinamide 1 29. Appropriate amount of spices
(製造方法) A:將成分(1)~(8)均勻地以三滾輪機處理。 B:將成分(9)~(11)均勻地溶解。 C:將成分(12)~(23)於75℃均勻地分散。 D:將C加入B中,於75℃進行乳化。 E:將D冷卻至50℃。 F:將成分(24)~(29)加入E中,並均勻地混合。 G:將A添加至F中,並均勻地混合。 H:將G進行填充容器後,獲得BB乳霜。 (manufacturing method) A: Evenly process ingredients (1) to (8) with a three-roller machine. B: Dissolve ingredients (9) to (11) uniformly. C: Disperse components (12) to (23) uniformly at 75°C. D: Add C to B and emulsify at 75°C. E: Cool D to 50°C. F: Add ingredients (24) to (29) to E and mix evenly. G: Add A to F and mix evenly. H: After filling the container with G, BB cream is obtained.
如以上地進行而獲得的BB乳霜,係於外觀顏色與塗抹顏色無落差、無高溫下之排液、化妝膜之均勻性、停止之平順度、塗抹時無使用感之變化上優異者。The BB cream obtained by proceeding as above is excellent in that there is no difference between the appearance color and the applied color, no drainage at high temperatures, uniformity of the makeup film, smoothness of stopping, and no change in the feeling of use during application.
實施例27 水中油型固型腮紅 (成分) (%) 1.經卵磷脂3%處理之氧化鈦 3 2.經卵磷脂3%處理之雲母鈦 3 3.經卵磷脂3%處理之絹雲母 4 4.經卵磷脂3%處理之滑石 10 5.聚氧乙烯(3)硬化蓖麻油 1 6.大豆磷脂質 1 7.蔗糖脂肪酸酯 0.5 8.硬脂酸異鯨蠟酯 5.5 9.香料 適量 10.對羥基苯甲酸甲酯 0.1 11.1,3-丁二醇 5 12.瓊脂 2 13.甘油 3 14.二甘油 1 15.純水 殘量 16.菸鹼醯胺 3 17.傳明酸 4 18.氧化鐵 2 Example 27 Oil-in-water solid blush (Element) (%) 1. Titanium oxide treated with 3% lecithin 3 2. Titanium mica treated with 3% lecithin 3 3. Sericite treated with 3% lecithin 4 4. Talc treated with 3% lecithin 10 5. Polyoxyethylene (3) hardened castor oil 1 6. Soybean phospholipid 1 7. Sucrose fatty acid ester 0.5 8.Isocetyl stearate 5.5 9. Appropriate amount of spices 10. Methyl parahydroxybenzoate 0.1 11.1,3-Butanediol 5 12. Agar 2 13. Glycerin 3 14. Diglycerol 1 15. Remaining amount of pure water 16.Nicotinamide 3 17. Tranexamic acid 4 18. Iron oxide 2
(製法) A.將成分(5)~(9)均勻地混合。 B.將成分(11)~(18)均勻地混合。 C.將(1)~(4)加入A中而混合分散。 D.將C加入B中而乳化,並添加成分(9)~(10)而均勻地混合。 E.將D填充於容器皿中,進行冷卻而獲得水中油型固型腮紅。 (making method) A. Mix ingredients (5) to (9) evenly. B. Mix ingredients (11) to (18) evenly. C. Add (1) to (4) to A and mix and disperse. D. Add C to B to emulsify, add components (9) to (10) and mix uniformly. E. Fill D into a container and cool it to obtain an oil-in-water solid blush.
如以上地進行而獲得的水中油型固型腮紅,係於外觀顏色與塗抹顏色無落差、無高溫下之排液、化妝膜之均勻性、停止之平順度、塗抹時無使用感之變化上優異者。The oil-in-water solid blush obtained by proceeding as above has no gap between the appearance color and the applied color, no drainage at high temperatures, uniformity of the makeup film, smoothness of stopping, and no change in the feel of use during application. Excellent ones.
無without
無。without.
無。without.
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021-215398 | 2021-12-29 | ||
JP2021215398 | 2021-12-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202333649A true TW202333649A (en) | 2023-09-01 |
Family
ID=86999158
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW111150416A TW202333649A (en) | 2021-12-29 | 2022-12-28 | Oil-in-water emulsion cosmetic |
Country Status (2)
Country | Link |
---|---|
TW (1) | TW202333649A (en) |
WO (1) | WO2023127937A1 (en) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7058943B2 (en) * | 2017-03-30 | 2022-04-25 | 株式会社コーセー | Oil-in-water emulsification composition |
JP2021161119A (en) * | 2020-03-31 | 2021-10-11 | 株式会社コーセー | Composition |
CN115335032A (en) * | 2020-03-31 | 2022-11-11 | 株式会社高丝 | Aqueous composition |
-
2022
- 2022-12-28 TW TW111150416A patent/TW202333649A/en unknown
- 2022-12-28 WO PCT/JP2022/048469 patent/WO2023127937A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2023127937A1 (en) | 2023-07-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5908674B2 (en) | Oily cosmetics | |
KR20180054573A (en) | Cosmetics | |
WO2017150519A1 (en) | Aqueous cosmetic composition | |
JP6110634B2 (en) | Oil-in-water emulsified cosmetic | |
JP6359295B2 (en) | Water-in-oil emulsified cosmetic and method for producing the same | |
JP6867168B2 (en) | Aerosol type cosmetics | |
JP7152161B2 (en) | External skin preparations or cosmetics | |
JP6465700B2 (en) | Gel lip cosmetic | |
JP2013035799A (en) | Creamy emulsion composition | |
JP5851725B2 (en) | Water-based or oil-in-water emulsified makeup cosmetics | |
TWI725002B (en) | Oil-in-water type ultraviolet protective cosmetic composition | |
WO2019188119A1 (en) | Hair cosmetic | |
JP7456866B2 (en) | aerosol cosmetics | |
JP2016166145A (en) | Oily makeup cosmetic | |
TW202333649A (en) | Oil-in-water emulsion cosmetic | |
JP6783512B2 (en) | Topical skin agent | |
JP2013199452A (en) | Oily cosmetic | |
JP7212563B2 (en) | Cosmetics for eyelashes | |
WO2020054590A1 (en) | Water-in-oil emulsion cosmetic composition | |
JP6005967B2 (en) | UV protection cosmetics | |
JP7462455B2 (en) | Oil-in-water emulsion composition | |
CN118159248A (en) | Oil-in-water type emulsified cosmetic | |
JP6918543B2 (en) | Topical skin preparations or cosmetic compositions | |
JP7387500B2 (en) | Oil-in-water emulsion composition | |
JP7335083B2 (en) | Cosmetic composition |